Literature DB >> 24406360

[Evaluation of patient safety culture among family and community medicine residents in a hospital A& E department].

C Jaraba Becerril1, M T Sartolo Romeo, M V Villaverde Royo, L Espuis Albas, M Rivas Jiménez.   

Abstract

BACKGROUND: Improving patient safety is a priority in all health care centres. It does not appear as a specific area of training in specialty programs. The aim of this study is to evaluate the safety culture of Family Medicine residents (MIR - Médico Interno Residente/Medical Internship and Residency).
METHODS: Transversal descriptive study. The Spanish version of the "Hospital Survey on Patient Safety" questionnaire was used. Strengths and opportunities for improving the service of the A & E Department were determined.
RESULTS: The most highly valued dimension was teamwork in the A & E Department. The worst qualified were "staffing" and "management support". None of those surveyed had notified any incidents in the unit.
CONCLUSIONS: Amongst the MIR surveyed there is a lack of knowledge about the channels for notifying adverse events, as well as a training deficiency in safety culture. This should be strengthened in the training of specialists in Family and Community Medicine.

Entities:  

Mesh:

Year:  2013        PMID: 24406360     DOI: 10.4321/s1137-66272013000300012

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  2 in total

1.  [Assessment of the patient safety culture in the ICU of a second level hospital at the end of the third COVID-19 wave].

Authors:  A Gil-Aucejo; S Martínez-Martín; P Flores-Sánchez; C Moyano-Hernández; P Sánchez-Morales; M Andrés-Martínez; E Calvo-Doñate; M Bataller-Guerrero; M A García-García
Journal:  Enferm Intensiva       Date:  2021-12-03

2.  [Patient safety culture in Family practice residents of Galicia].

Authors:  Manuel Portela Romero; Rosendo Bugarín González; María Sol Rodríguez Calvo
Journal:  Aten Primaria       Date:  2017-04-20       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.